Stock Taper
EARNINGS CALL ARCHIVE 4 CALLS ON FILE
AMLX — Amylyx Pharmaceuticals, Inc.
NASDAQ
FULL STOCK PAGE →

Q1 2026 Earnings Call Summary

MAY 7, 2026
REVENUE
$0
EPS
-$0.37 -32.1%
FREE CASH FLOW
-$36.9M -31.8%

No summary has been written for this call yet.